2010
DOI: 10.3386/w16146
|View full text |Cite
|
Sign up to set email alerts
|

Maternal Health and the Baby Boom

Abstract: Standard-Nutzungsbedingungen:Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Zwecken und zum Privatgebrauch gespeichert und kopiert werden.Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich machen, vertreiben oder anderweitig nutzen.Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, gelten abweichend von diesen Nutzungsbedingungen die in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
42
2
2

Year Published

2013
2013
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(48 citation statements)
references
References 22 publications
2
42
2
2
Order By: Relevance
“…5 Unsurprisingly, the relationship between life expectancy at age 30 (or 50) in 1960 and CVD is negative and statistically significant at the 1 percent level (columns 1 and 2). Thus, states with higher death rates from CVDs also had lower adult life expectancies, suggesting that in fact CVD mortality was quantitatively 5 The covariates are: initial mortality and income important. More importantly for our analysis, however, we also find that CVD is completely unrelated to changes in life expectancy between 1940 and 1960, which implies that the CVD shock has no predictive power for life expectancy in the pretreatment period (columns 3 and 4).…”
Section: Background: the Cardiovascular Revolutionmentioning
confidence: 99%
“…5 Unsurprisingly, the relationship between life expectancy at age 30 (or 50) in 1960 and CVD is negative and statistically significant at the 1 percent level (columns 1 and 2). Thus, states with higher death rates from CVDs also had lower adult life expectancies, suggesting that in fact CVD mortality was quantitatively 5 The covariates are: initial mortality and income important. More importantly for our analysis, however, we also find that CVD is completely unrelated to changes in life expectancy between 1940 and 1960, which implies that the CVD shock has no predictive power for life expectancy in the pretreatment period (columns 3 and 4).…”
Section: Background: the Cardiovascular Revolutionmentioning
confidence: 99%
“…While such a channel has been identified as empirically relevant (e.g., Field et al, 2009), it is by no means the only one. As Jayachandran and Lleras-Muney (2009) and Albanesi and Olivetti (2014) show, reductions in maternal mortality also serve as a trigger by fostering investments in female education, which ultimately translate into greater labor participation and lower fertility. An examination of this channel would call for an extension of our model to incorporate gender-specific educational investments.…”
Section: Discussionmentioning
confidence: 99%
“…This allows us to highlight the role of general equilibrium repercussions and to explicitly calculate the timing of the economic transition. By emphasizing the role of female health in economic development, our model bears some resemblance to the theoretical analyses in Jayachandran and Lleras-Muney (2009), Albanesi andOlivetti (2014), de la Croix andVander Donckt (2010), and Agénor et al (2010). The first two of these articles examine how fertility and educational choices at the household level depend on maternal mortality but do not extend this analysis into a macroeconomic framework.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, states with higher death rates from CVDs also had lower adult life expectancies, suggesting that in fact CVD mortality was quantitatively 5 The covariates are: initial mortality and income important. More importantly for our analysis, however, we also find that CVD is completely unrelated to changes in life expectancy between 1940 and 1960, which implies that the CVD shock has no predictive power for life expectancy in the pretreatment period (columns 3 and 4).…”
Section: Background: the Cardiovascular Revolutionmentioning
confidence: 99%